Endurant Capital Management LP Axsome Therapeutics, Inc. Transaction History

Endurant Capital Management LP

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$39.94 - $79.72 $449,884 - $897,966	11,264 New	11,264 $868,000
Q2 2022 Aug 15, 2022	SELL	$21.74 - $46.75 $1.85 Million - $3.98 Million	-85,053 Reduced 84.8%	15,246 $584,000
Q1 2022 May 16, 2022	BUY	$23.7 - $41.39 $1.06 Million - $1.85 Million	44,670 Added 80.3%	100,299 $4.15 Million
Q4 2021 Feb 14, 2022	BUY	$30.7 - $43.36 $109,936 - $155,272	3,581 Added 6.88%	55,629 $2.1 Million
Q3 2021 Nov 15, 2021	BUY	$19.91 - $68.26 $1.04 Million - $3.55 Million	52,048 New	52,048 $1.72 Million
Q2 2020 Aug 14, 2020	SELL	$49.87 - $98.69 $616,742 - $1.22 Million	-12,367 Closed	0 $0
Q1 2020 May 15, 2020	BUY	$41.2 - $101.31 $50,099 - $123,192	1,216 Added 10.9%	12,367 $728,000
Q4 2019 Feb 14, 2020	BUY	$16.71 - $106.24 $186,333 - $1.18 Million	11,151 New	11,151 $1.15 Million
Q2 2019 Aug 14, 2019	SELL	$13.46 - $25.75 $703,527 - $1.35 Million	-52,268 Closed	0 $0
Q1 2019 May 15, 2019	SELL	$2.63 - $16.34 $412,718 - $2.56 Million	-156,927 Reduced 75.01%	52,268 $744,000
Q4 2018 Feb 14, 2019	BUY	$2.0 - $4.15 $228,020 - $473,141	114,010 Added 119.78%	209,195 $590,000
Q3 2018 Nov 14, 2018	BUY	$2.3 - $3.55 $218,925 - $337,906	95,185 New	95,185 $328,000

325

37.7M

912K

855K

Ticker AXSM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 42,878,000
Market Cap $3.89B
Description
Axsome Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel therapies for central nervous system (CNS) disorders in the United States. The company's product pipeline includes AXS-05, a therapeutic for the treatment of major depressive disorder and resistant depression disorders; and that is in the Phase III clinic...

Get notified when there are updates to the investment portfolio of Endurant Capital Management LP, based on Form 13F filings with the SEC.

Stay updated on Endurant Capital Management LP with notifications on news.